Abstract
Multiple-unit type oral modified drug delivery system of aceclofenac was developed by ionotropic gelation method for targeted drug delivery and to reduce the chances of side effects. Various batches of microspheres were developed by ionotropic gelation method using single and blends of polymers. Along with usual physical properties, the microspheres were also subjected to enteric nature, in-vitro drug release and mucoadhesion studies to investigate a possible sustained drug release and their use in in-vivo as a gastro-protective system for aceclofenac. It was observed that prepared microspheres could be able to restrict the drug release in stomach region and prolong the drug release by adhering on to the intestinal mucosa. In vitro drug release suggested a combination of drug diffusion and spheres erosion could be the release mechanism and it was also found that blend of polymers is more effective in sustaining the drug release than either polymer. Optimized microsphere formulation suggested 71.03 ± 4.94 % edema inhibition at 12 hours and shelf life of about 2.32 years at room temperature. Algino-gelatin multiunit dosage system exhibits promising properties for once daily targeted release form of aceclofenac in order to reduce the side effects and enhance the patient’s compliance.
Keywords: Algino-gelatin microspheres, enteric nature, gastro-protection, in-vivo study, mucoadhesion, targeted release.
Drug Delivery Letters
Title:Design, Characterization and Pre-Clinical Evaluation of Aceclofenac Loaded Algino-gelatin Microspheres for Targeted Drug Delivery
Volume: 3 Issue: 2
Author(s): Santanu Chakraborty, Madhusmruti Khandai and Ashoke Kumar Ghosh
Affiliation:
Keywords: Algino-gelatin microspheres, enteric nature, gastro-protection, in-vivo study, mucoadhesion, targeted release.
Abstract: Multiple-unit type oral modified drug delivery system of aceclofenac was developed by ionotropic gelation method for targeted drug delivery and to reduce the chances of side effects. Various batches of microspheres were developed by ionotropic gelation method using single and blends of polymers. Along with usual physical properties, the microspheres were also subjected to enteric nature, in-vitro drug release and mucoadhesion studies to investigate a possible sustained drug release and their use in in-vivo as a gastro-protective system for aceclofenac. It was observed that prepared microspheres could be able to restrict the drug release in stomach region and prolong the drug release by adhering on to the intestinal mucosa. In vitro drug release suggested a combination of drug diffusion and spheres erosion could be the release mechanism and it was also found that blend of polymers is more effective in sustaining the drug release than either polymer. Optimized microsphere formulation suggested 71.03 ± 4.94 % edema inhibition at 12 hours and shelf life of about 2.32 years at room temperature. Algino-gelatin multiunit dosage system exhibits promising properties for once daily targeted release form of aceclofenac in order to reduce the side effects and enhance the patient’s compliance.
Export Options
About this article
Cite this article as:
Chakraborty Santanu, Khandai Madhusmruti and Ghosh Kumar Ashoke, Design, Characterization and Pre-Clinical Evaluation of Aceclofenac Loaded Algino-gelatin Microspheres for Targeted Drug Delivery, Drug Delivery Letters 2013; 3 (2) . https://dx.doi.org/10.2174/2210303111303020001
DOI https://dx.doi.org/10.2174/2210303111303020001 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections
Infectious Disorders - Drug Targets VEGF and HIF in Renal Cell Carcinogenesis
Recent Patents on Biomarkers Brevibacillus Expression System: Host-Vector System for Efficient Production of Secretory Proteins
Current Pharmaceutical Biotechnology Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis
Current Cancer Therapy Reviews Targeting Angiogenesis in Head and Neck Cancer
Current Cancer Drug Targets Innate Immunity in Lophotrochozoans: The Annelids
Current Pharmaceutical Design Patent Selections:
Recent Patents on Food, Nutrition & Agriculture HDL - Cholesterol: The New Target for Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Sumoylation Pathway as Potential Therapeutic Targets in Cancer
Current Molecular Medicine Indoleamine 2,3-Dioxygenase in Materno-Fetal Interaction
Current Drug Metabolism Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases
Current Pharmacogenomics and Personalized Medicine Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Current Pharmaceutical Biotechnology Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Current Cancer Drug Targets Cytokine Targeting in Osteoarthritis
Current Drug Targets Patent Selections
Recent Patents on Drug Delivery & Formulation An Update on NLRP3 Inflammasome Activation by Engineered Nanomaterials
Current Bionanotechnology (Discontinued) Extracellular Superoxide and the Growth of Pancreatic Carcinoma
Current Cancer Therapy Reviews An Overall Picture of Chemokine Receptors: Basic Research and Drug Development
Current Pharmaceutical Design Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance
Current Cancer Drug Targets Strategy for the Treatment of Helicobacter pylori Infection
Current Pharmaceutical Design